• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞/基质细胞疗法治疗代谢综合征:潜在的临床应用?

Mesenchymal Stem/Stromal Cells Therapy for Metabolic Syndrome: Potential Clinical Application?

机构信息

Division of Vascular Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.

出版信息

Stem Cells. 2023 Oct 8;41(10):893-906. doi: 10.1093/stmcls/sxad052.

DOI:10.1093/stmcls/sxad052
PMID:37407022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10560401/
Abstract

Mesenchymal stem/stromal cells (MSCs), a class of cells with proliferative, immunomodulatory, and reparative functions, have shown therapeutic potential in a variety of systemic diseases, including metabolic syndrome (MetS). The cluster of morbidities that constitute MetS might be particularly amenable for the application of MSCs, which employ an arsenal of reparative actions to target multiple pathogenic pathways simultaneously. Preclinical studies have shown that MSCs can reverse pathological changes in MetS mainly by inhibiting inflammation, improving insulin resistance, regulating glycolipid metabolism, and protecting organ function. However, several challenges remain to overcome before MSCs can be applied for treating MetS. For example, the merits of autologous versus allogeneic MSCs sources remain unclear, particularly with autologous MSCs obtained from the noxious MetS milieu. The distinct characteristics and relative efficacy of MSCs harvested from different tissue sources also require clarification. Moreover, to improve the therapeutic efficacy of MSCs, investigators have explored several approaches that improved therapeutic efficacy but may involve potential safety concerns. This review summarized the potentially useful MSCs strategy for treating MetS, as well as some hurdles that remain to be overcome. In particular, larger-scale studies are needed to determine the therapeutic efficacy and safety of MSCs for clinical application.

摘要

间充质干细胞(MSCs)是一类具有增殖、免疫调节和修复功能的细胞,在多种系统性疾病中显示出治疗潜力,包括代谢综合征(MetS)。构成 MetS 的多种疾病可能特别适合应用 MSCs,MSCs 利用一系列修复作用来同时针对多种致病途径。临床前研究表明,MSCs 可以通过抑制炎症、改善胰岛素抵抗、调节糖脂代谢和保护器官功能来逆转 MetS 的病理变化。然而,在 MSCs 可用于治疗 MetS 之前,仍有一些挑战需要克服。例如,自体与同种异体 MSCs 来源的优点仍不清楚,特别是从有害的 MetS 环境中获得的自体 MSCs。不同组织来源的 MSCs 的独特特征和相对疗效也需要阐明。此外,为了提高 MSCs 的治疗效果,研究人员探索了几种可以提高治疗效果但可能涉及潜在安全问题的方法。本综述总结了用于治疗 MetS 的潜在有用的 MSCs 策略,以及仍需克服的一些障碍。特别是需要更大规模的研究来确定 MSCs 用于临床应用的治疗效果和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10560401/dba686ad3c5e/sxad052_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10560401/dba686ad3c5e/sxad052_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10560401/dba686ad3c5e/sxad052_fig3.jpg

相似文献

1
Mesenchymal Stem/Stromal Cells Therapy for Metabolic Syndrome: Potential Clinical Application?间充质干细胞/基质细胞疗法治疗代谢综合征:潜在的临床应用?
Stem Cells. 2023 Oct 8;41(10):893-906. doi: 10.1093/stmcls/sxad052.
2
The metabolic syndrome alters the miRNA signature of porcine adipose tissue-derived mesenchymal stem cells.代谢综合征改变了猪脂肪组织来源间充质干细胞的 miRNA 特征。
Cytometry A. 2018 Jan;93(1):93-103. doi: 10.1002/cyto.a.23165. Epub 2017 Jul 5.
3
Metabolic Syndrome Induces Release of Smaller Extracellular Vesicles from Porcine Mesenchymal Stem Cells.代谢综合征诱导猪骨髓间充质干细胞释放更小的细胞外囊泡。
Cell Transplant. 2019 Sep-Oct;28(9-10):1271-1278. doi: 10.1177/0963689719860840. Epub 2019 Jun 28.
4
Mesenchymal stem cell-derived extracellular vesicles for metabolic syndrome therapy: Assessing efficacy with nuclear magnetic resonance spectroscopy.间充质干细胞衍生的细胞外囊泡用于代谢综合征治疗:用核磁共振波谱评估疗效
Cell Biochem Funct. 2023 Dec;41(8):1044-1059. doi: 10.1002/cbf.3881. Epub 2023 Nov 6.
5
Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve the Renal Microvasculature in Metabolic Renovascular Disease in Swine.间质干细胞衍生的细胞外囊泡改善猪代谢性血管疾病的肾脏微血管。
Cell Transplant. 2018 Jul;27(7):1080-1095. doi: 10.1177/0963689718780942. Epub 2018 Jun 28.
6
Mesenchymal Stem/Stromal Cells Reverse Adipose Tissue Inflammation in Pigs with Metabolic Syndrome and Renovascular Hypertension.间充质干/基质细胞可逆转患有代谢综合征和肾血管性高血压猪的脂肪组织炎症。
Cells. 2025 Jan 2;14(1):40. doi: 10.3390/cells14010040.
7
Metabolic Syndrome Interferes with Packaging of Proteins within Porcine Mesenchymal Stem Cell-Derived Extracellular Vesicles.代谢综合征干扰猪间充质干细胞衍生细胞外囊泡中蛋白质的包装。
Stem Cells Transl Med. 2019 May;8(5):430-440. doi: 10.1002/sctm.18-0171. Epub 2019 Feb 1.
8
Alterations in genetic and protein content of swine adipose tissue-derived mesenchymal stem cells in the metabolic syndrome.代谢综合征中猪脂肪组织来源间充质干细胞的基因和蛋白质含量变化
Stem Cell Res. 2019 May;37:101423. doi: 10.1016/j.scr.2019.101423. Epub 2019 Mar 18.
9
Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives.基于人间质干细胞/基质细胞的疗法治疗糖尿病:实验和临床观点。
Stem Cell Res Ther. 2024 Oct 29;15(1):384. doi: 10.1186/s13287-024-03974-z.
10
Single high-dose intravenous injection of Wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome.单次大剂量静脉注射牙髓间充质干细胞在代谢综合征大鼠模型中发挥保护作用。
Stem Cell Res Ther. 2024 Jun 5;15(1):160. doi: 10.1186/s13287-024-03769-2.

引用本文的文献

1
The effects of Klotho delivering mesenchymal stem cell-derived small extracellular vesicles on acute kidney injury.递送间充质干细胞来源的小细胞外囊泡的Klotho对急性肾损伤的影响。
J Nanobiotechnology. 2025 Jun 7;23(1):427. doi: 10.1186/s12951-025-03499-4.
2
Tailoring cell therapies for diabetic metabolic phenotypes: a comparative study on the efficacy of various umbilical cord-derived cell regimens.针对糖尿病代谢表型定制细胞疗法:不同脐带源细胞方案疗效的比较研究
Stem Cells Transl Med. 2025 Feb 11;14(2). doi: 10.1093/stcltm/szae083.

本文引用的文献

1
Placental mesenchymal stem cells restore glucose and energy homeostasis in obesogenic adipocytes.胎盘间充质干细胞恢复肥胖诱导脂肪细胞的葡萄糖和能量稳态。
Cell Tissue Res. 2023 Jan;391(1):127-144. doi: 10.1007/s00441-022-03693-y. Epub 2022 Oct 13.
2
Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus.将脂肪间充质干细胞重编程为胰岛 β 细胞治疗犬糖尿病。
Stem Cell Res Ther. 2022 Jul 28;13(1):370. doi: 10.1186/s13287-022-03020-w.
3
Adipose-derived stromal cells reverse insulin resistance through inhibition of M1 expression in a type 2 diabetes mellitus mouse model.
脂肪来源的基质细胞通过抑制 2 型糖尿病小鼠模型中 M1 的表达来逆转胰岛素抵抗。
Stem Cell Res Ther. 2022 Jul 26;13(1):357. doi: 10.1186/s13287-022-03046-0.
4
Metformin and vitamin D modulate adipose-derived stem cell differentiation towards the beige phenotype.二甲双胍和维生素 D 调节脂肪来源干细胞向米色表型分化。
Adipocyte. 2022 Dec;11(1):356-365. doi: 10.1080/21623945.2022.2085417.
5
A long-term anti-inflammation markedly alleviated high-fat diet-induced obesity by repeated administrations of overexpressing IL10 human umbilical cord-derived mesenchymal stromal cells.长期抗炎显著减轻了反复给予过表达 IL10 的人脐带间充质干细胞对高脂肪饮食诱导肥胖的影响。
Stem Cell Res Ther. 2022 Jun 17;13(1):259. doi: 10.1186/s13287-022-02935-8.
6
Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial.脐带间充质干细胞治疗中国成人 2 型糖尿病的疗效和安全性:一项单中心、双盲、随机、安慰剂对照的 II 期临床试验。
Stem Cell Res Ther. 2022 May 3;13(1):180. doi: 10.1186/s13287-022-02848-6.
7
Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies.间质干细胞/基质细胞衰老:特征、机制和对抗策略。
Stem Cells Transl Med. 2022 Apr 29;11(4):356-371. doi: 10.1093/stcltm/szac004.
8
Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement.干细胞移植治疗 1 型糖尿病:从胰岛素替代到β细胞替代。
Front Endocrinol (Lausanne). 2022 Mar 18;13:859638. doi: 10.3389/fendo.2022.859638. eCollection 2022.
9
Human placental mesenchymal stromal cell therapy restores the cytokine efflux and insulin signaling in the skeletal muscle of obesity-induced type 2 diabetes rat model.人胎盘间充质基质细胞治疗可恢复肥胖诱导 2 型糖尿病大鼠模型骨骼肌中的细胞因子外排和胰岛素信号转导。
Hum Cell. 2022 Mar;35(2):557-571. doi: 10.1007/s13577-021-00664-3. Epub 2022 Jan 29.
10
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.代谢综合征:2021 年病理生理学和治疗管理的最新进展。
Int J Mol Sci. 2022 Jan 12;23(2):786. doi: 10.3390/ijms23020786.